Cutler Group’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-9,400
Closed -$196K 6664
2021
Q1
$196K Sell
9,400
-1,000
-10% -$23.1K 0.01% 1290
2020
Q4
$238K Buy
+10,400
New +$198K 0.01% 988
2020
Q1
Sell
-20,284
Closed -$505K 4905
2019
Q4
$505K Sell
20,284
-2,347
-10% -$47.6K 0.03% 448
2019
Q3
$384K Buy
22,631
+13,231
+141% +$241K 0.04% 431
2019
Q2
$213K Buy
+9,400
New +$254K 0.02% 683
2018
Q4
Sell
-2,600
Closed -$74K 4840
2018
Q3
$74K Buy
+2,600
New +$78.1K 0.01% 1371
2017
Q3
Sell
-9,867
Closed -$275K 7023
2017
Q2
$275K Buy
9,867
+2,014
+26% +$45.6K 0.01% 1046
2017
Q1
$134K Buy
7,853
+6,453
+461% +$90.4K 0.01% 1489
2016
Q4
$16K Buy
1,400
+1,000
+250% +$12.9K ﹤0.01% 3724
2016
Q3
$6K Sell
400
-100
-20% -$1.51K ﹤0.01% 4846
2016
Q2
$6K Buy
500
+100
+25% +$1.56K ﹤0.01% 4813
2016
Q1
$7K Buy
400
+100
+33% +$1.81K ﹤0.01% 4540
2015
Q4
$6K Buy
+300
New +$5.93K ﹤0.01% 4768

Other funds holding XENT

Cutler Group's XENT Position: Q2 2021 in Review

Cutler Group sold out of Intersect ENT, Inc (XENT) in Q2 2021, closing a stake of 9,400 shares — an estimated $196K sold.

Cutler Group first reported a position in XENT in Q4 2015 and held it in 13 quarters. The position peaked at $505K in Q4 2019. 107 funds tracked by Wall St. Rank hold XENT as of Q2 2021.

  • Cutler Group reported no remaining Intersect ENT, Inc position as of Q2 2021 after selling out during the quarter.
  • Cutler Group sold 9,400 Intersect ENT, Inc shares in Q2 2021, an estimated $196K.
  • Cutler Group first reported a position in Intersect ENT, Inc in Q4 2015 and held it in 13 quarters.
  • Cutler Group's Intersect ENT, Inc position peaked at $505K in Q4 2019.
  • 107 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2021.

Based on Cutler Group's 13F filing for Q2 2021, filed 19 Jul 2021.